BTCY
Biotricity Inc
Price:  
0.46 
Volume:  
532,001.00
Canada | Health Care Technology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BTCY WACC - Weighted Average Cost of Capital

The WACC of Biotricity Inc (BTCY) is 6.5%.

The Cost of Equity of Biotricity Inc (BTCY) is 6.25%.
The Cost of Debt of Biotricity Inc (BTCY) is 9.10%.

Range Selected
Cost of equity 4.90% - 7.60% 6.25%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 11.20% 9.10%
WACC 5.1% - 8.0% 6.5%
WACC

BTCY WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.11 0.41
Additional risk adjustments 0.5% 1.0%
Cost of equity 4.90% 7.60%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1.96 1.96
Cost of debt 7.00% 11.20%
After-tax WACC 5.1% 8.0%
Selected WACC 6.5%

BTCY's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for BTCY:

cost_of_equity (6.25%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.11) + risk_adjustments (0.75%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.